The “Nuclear Medicine and Radiopharmaceutical Manufacturing Market, 2020-2030” report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals
To order this detailed 320+ page report, please visit this -
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-customization.html
Key Inclusions
§
A detailed assessment
of the current market landscape with respect to the players (industry and
non-industry) involved in manufacturing radiopharmaceuticals. It features
information on the year of establishment, company size, purpose of production
(fulfilling in-house requirements / for contract services), location of
headquarters, location of manufacturing facilities, scale of production,
applications of radiopharmaceuticals (in diagnosis, therapeutics and theragnostic),
type of diagnostic radiopharmaceuticals (PET and SPECT), type of therapeutic
radiopharmaceuticals (alpha emitters, beta emitters and others), target
therapeutic area (cardiology, oncology, neurology, thyroid and others) and
services offered.
§
An insightful
four-dimensional comparison of the radiopharmaceutical manufacturers, based on
supplier power (year of establishment), product portfolio (number of isotopes
being manufactured for various applications targeting different therapeutic
areas) of the manufacturer, scale at which they manufacture their respective
products and company size.
§
Tabulated profiles of
key industry players based in North America, Europe and Asia-Pacific
(shortlisted based on the company size of the players), featuring a brief
overview of the company, a list of products and manufacturing facilities,
recent developments and an informed future outlook.
§
An analysis of recent
partnerships and collaborations inked in this domain since 2017, based on
several parameters, such as the type of partnership, year of partnership, type
of radioisotope involved, therapeutic area mentioned in the agreement,
application of the radioisotope mentioned in the agreement, and a schematic
representation showcasing the players that have forged the maximum number of
alliances. Furthermore, we have provided a world map representation of the
deals inked in this field, highlighting those that have been established within
and across different continents.
§
A detailed discussion
on the supply chain model of medical isotope Mo-99 (Tc-99m), highlighting the
main steps of the supply chain, from irradiation of uranium targets in nuclear research reactors to the administration of
Tc-99m to patients. Along with this, it describes the structure of the industry
and product market at each step.
To request
for Sample Report – https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-sample.html
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§
Target Therapeutic Area
§
Cardiology
§
Neurology
§
Oncology
§
Thyroid
§
Others
- Application
Area
§
Diagnostic
§
Therapeutic
§
Type of Diagnostic Radiopharmaceuticals
§
PET
§
SPECT
§
Type of Therapeutic Radiopharmaceuticals
§
Alpha Emitters
§
Beta Emitters
§
Others
§
Purpose of Production
§
In-House
§
Outsourcing
- Key
Geographical Region
§
North America
§
Europe
§
Asia-Pacific and the Rest of the World
Transcripts
of interviews held with the following senior level representatives of
stakeholder companies
§
J
James
Davis, Vice President Quality / R&D, Shertech Laboratories
§ Andreas
Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical
School
§ Jan
Pruim, Professor of Medical Imaging / Nuclear Medicine Physician,
University Medical Center of Groningen
§ Michael
van Dam, Professor, Crump Institute for Molecular Imaging, Molecular &
Medical Pharmacology
§ Anonymous,
ITM Isotopen Technologien München
To request for Customize Report – https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing/request-customization.html
Key Questions Answered
§
Who are
the leading industry and non-industry players engaged in the nuclear medicine and
radiopharmaceutical manufacturing market?
§
For which application and disease indications are the
radiopharmaceuticals being manufactured?
§
What are the various type of radionuclides being
manufactured for the formulation of radiopharmaceuticals?
§
What is the relative competitiveness of manufacturers
involved in the nuclear medicine and radiopharmaceutical manufacturing?
§
Which partnership models are commonly adopted by the
radiopharmaceutical manufacturers in this industry?
§
What is the supply chain process for medical isotope Mo-99
/ Tc-99m?
§
What are the key factors that are likely to influence the
evolution of the nuclear medicine and radiopharmaceutical manufacturing
market?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
You may also be interested in the following titles:
2.
Live Biotherapeutic Products and Microbiome Contract
Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030
3.
China Biopharmaceutical Contract Manufacturing
Market, 2020 - 2030
4.
Continuous
Manufacturing Market (Small Molecules and Biologics), 2020 – 2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment